📣 VC round data is live. Check it out!
- Public Comps
- Ilex Medical
Ilex Medical Valuation Multiples
Discover Ilex Medical's revenue and EBITDA valuation multiples and investment history, alongside public comparables like RxSight, TriSalus Life Sciences, Asterasys, Medinice and more.
Ilex Medical Overview
About Ilex Medical
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
Founded
1977
HQ

Employees
N/A
Website
Financials (FY)
EV
$145M
Valuation Multiples
Start free trialIlex Medical Financials
Ilex Medical reported last fiscal year revenue of $330M and EBITDA of $45M.
In the same fiscal year, Ilex Medical generated $75M in gross profit, $45M in EBITDA, and $20M in net income.
Ilex Medical P&L
In the most recent fiscal year, Ilex Medical reported revenue of $330M and EBITDA of $45M.
Ilex Medical is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 14%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Ilex Medical Stock Performance
Ilex Medical has current market cap of $204M, and enterprise value of $145M.
Market Cap Evolution
Ilex Medical's stock price is $18.23.
Ilex Medical share price decreased by 0.9% in the last 30 days, and by 12.2% in the last year.
Ilex Medical has an EPS (earnings per share) of $1.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $145M | $204M | -0.1% | -0.9% | -10.8% | -12.2% | $1.76 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIlex Medical Valuation Multiples
Ilex Medical trades at 0.4x EV/Revenue multiple, and 3.3x EV/EBITDA.
Ilex Medical Financial Valuation Multiples
As of June 3, 2026, Ilex Medical has market cap of $204M and EV of $145M.
Ilex Medical has a P/E ratio of 10.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ilex Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ilex Medical Margins & Growth Rates
In the most recent fiscal year, Ilex Medical reported gross margin of 23%, EBITDA margin of 14%, and net margin of 6%.
Ilex Medical Margins
Ilex Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ilex Medical Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Ilex Medical Competitors
Ilex Medical competitors include RxSight, TriSalus Life Sciences, Asterasys, Medinice, Lucid Diagnostics, Sanara MedTech, Pro-Dex, Huons Co, Utah Medical and Anika Therapeutics.
Most Ilex Medical public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| (0.0x) | (0.0x) | 0.1x | 0.0x | |||
| 4.0x | 3.7x | (11.1x) | (12.2x) | |||
| 7.5x | 6.3x | 22.7x | 18.2x | |||
| - | - | (111.9x) | - | |||
| 44.1x | 35.6x | (3.7x) | (4.0x) | |||
| 2.2x | 2.1x | 13.6x | 13.7x | |||
| 3.3x | 2.9x | 15.7x | - | |||
| 0.7x | - | 5.2x | - | |||
This data is available for Pro users. Sign up to see all Ilex Medical competitors and their valuation data. Start Free Trial | ||||||
Investments by Ilex Medical
Ilex Medical has invested in 2 companies to date.
Latest investment by Ilex Medical was on February 18th 2026. Ilex Medical invested in Starget Pharma in their $18M Series A round (EV/Revenue multiple available to Pro users).
Latest Investments by Ilex Medical
| Description | Starget Pharma is a clinical-stage radiopharmaceutical company developing targeted therapies for solid tumors. Its pipeline features alpha-emitter conjugates that selectively deliver radioisotopes to prostate, lung, and other cancer tissues. Headquartered in Montreal, Canada, the firm advances molecules through phase I and II trials. | Scopio Labs is a Tel Aviv-headquartered provider of full-field digital morphology systems for hematology. The platform uses AI to analyze high-resolution images from blood samples and bone marrow aspirates, revealing thousands of cells for advanced diagnostic insights. Scopio enables hematologists to uncover previously inaccessible data patterns in routine samples. |
| HQ Country | ||
| HQ City | Ramat HaSharon | Tel Aviv |
| Deal Date | 18 Feb 2026 | 9 Feb 2022 |
| Round | Series A | Series C |
| Raised | $18M | $50M |
| Investors | BRF; Cancer Focus Fund; Ilex Medical; Louisiana Economic Development | Aurum Ventures MKI; Ilex Medical; LR Group; Lumir Ventures; Mivtach Shamir Holdings; Mizrahi-Tefahot Bank; OTV; OurCrowd |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Ilex Medical investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ilex Medical
| When was Ilex Medical founded? | Ilex Medical was founded in 1977. |
| Where is Ilex Medical headquartered? | Ilex Medical is headquartered in Israel. |
| Is Ilex Medical publicly listed? | Yes, Ilex Medical is a public company listed on Tel Aviv Stock Exchange. |
| What is the stock symbol of Ilex Medical? | Ilex Medical trades under ILX ticker. |
| When did Ilex Medical go public? | Ilex Medical went public in 1995. |
| Who are competitors of Ilex Medical? | Ilex Medical main competitors include RxSight, TriSalus Life Sciences, Asterasys, Medinice, Lucid Diagnostics, Sanara MedTech, Pro-Dex, Huons Co, Utah Medical, Anika Therapeutics. |
| What is the current market cap of Ilex Medical? | Ilex Medical's current market cap is $204M. |
| What is the current revenue of Ilex Medical? | Ilex Medical's last fiscal year revenue is $330M. |
| What is the current EV/Revenue multiple of Ilex Medical? | Current revenue multiple of Ilex Medical is 0.4x. |
| Is Ilex Medical profitable? | No, Ilex Medical is not profitable. |
| How many companies Ilex Medical has acquired to date? | Ilex Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Ilex Medical has invested to date? | As of June 2026, Ilex Medical has invested in 2 companies. |
| What was the last Ilex Medical investment? | On 18th February 2026 Ilex Medical invested in Starget Pharma, participating in a $18M Series A round, alongside BRF, Cancer Focus Fund, and Louisiana Economic Development. |
| In what companies Ilex Medical invested in? | Ilex Medical invested in Scopio Labs and Starget Pharma. |
See public comps similar to Ilex Medical
Lists including Ilex Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
